Stewart Self Care & Legal Practice Test

In pharmacovigilance, spotting and collecting reports of suspected adverse drug reactions is essential to protect patient safety. This process relies on clinicians, patients, and manufacturers submitting ADR reports to safety authorities so regulators can detect new risks and take action, such as updating labels or issuing warnings. Because of its role in safeguarding the public, reporting ADRs is expected and often legally required in many jurisdictions, not optional. ADRs can occur in any care setting, not just in hospital, so reports come from a variety of sources. Therefore, ADRs are described as something that must be reported to pharmacovigilance authorities.